Molecule Details
| InChIKey | IIDJRNMFWXDHID-UHFFFAOYSA-N |
|---|---|
| Compound Name | Risedronate |
| Canonical SMILES | O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.05 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00884 |
|---|---|
| Drug Name | Risedronic acid |
| CAS Number | 105462-24-6 |
| Groups | approved investigational |
| ATC Codes | M05BB07 M05BB02 M05BB04 M05BA07 |
| Description | Risedronic acid is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. It functions by preventing resorption of bone[FDA Label][A959]. |
Categories: Agents Causing Muscle Toxicity Bisphosphonates Bone Density Conservation Agents Calcium-Regulating Hormones and Agents Cardiovascular Agents Drugs Affecting Bone Structure and Mineralization Drugs for Treatment of Bone Diseases Membrane Transport Modulators Musculo-Skeletal System Organophosphonates Organophosphorus Compounds Pyridines
Cross-references: BindingDB: 12576 ChEBI: 8869 CHEMBL923 ChemSpider: 5055 Drugs Product Database (DPD): 11819 C08233 D08484 PDB: RIS PharmGKB: PA451255 PubChem:5245 PubChem:46507526 RxCUI: 55685 Therapeutic Targets Database: DAP000658 Wikipedia: Risedronic_acid ZINC: ZINC000001531009